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Abstract
Down syndrome (DS) is the most common genetic cause of intellectual disability, and arises
from trisomy of human chromosome 21. Accumulating evidence from studies of both DS
patient tissue and mouse models has suggested that synaptic dysfunction is a key factor in
the disorder. The presence of several genes within the DS trisomy that are either directly or
indirectly linked to synaptic vesicle (SV) endocytosis suggested that presynaptic dysfunc-
tion could underlie some of these synaptic defects. Therefore we determined whether SV
recycling was altered in neurons from the Ts65Dn mouse, the best characterised model of
DS to date. We found that SV exocytosis, the size of the SV recycling pool, clathrin-medi-
ated endocytosis, activity-dependent bulk endocytosis and SV generation from bulk endo-
somes were all unaffected by the presence of the Ts65Dn trisomy. These results were
obtained using battery of complementary assays employing genetically-encoded fluores-
cent reporters of SV cargo trafficking, and fluorescent and morphological assays of fluid-
phase uptake in primary neuronal culture. The absence of presynaptic dysfunction in central
nerve terminals of the Ts65Dn mouse suggests that future research should focus on the
established alterations in excitatory / inhibitory balance as a potential route for future
pharmacotherapy.
Introduction
Down syndrome (DS) is the most common genetic cause of intellectual disability, and arises
from the presence of an extra copy of human chromosome 21 (Hsa21) [1]. Patients with DS
display reductions in synapse number [2], decreased dendrite arborisation [3,4] and an imbal-
ance between excitatory and inhibitory input [5,6], suggesting synaptic dysfunction is a key fac-
tor in the disorder. Altered presynaptic function could underlie some of these perturbations,
since several key endocytosis genes are present on Hsa21. Furthermore, enlarged early endo-
somes are observed in DS brain from before birth [7]. This may result from perturbed synaptic
vesicle (SV) recycling, since evidence is accumulating that some SV endocytosis modes inter-
sect with classical endosomal trafficking routes [8].
The activity-dependent fusion (exocytosis) and efficient retrieval (endocytosis) of SVs at the
presynapse is essential for synaptic transmission, and disruption of these processes can result
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in a number of neurodevelopmental disorders [9]. Hsa21 carries genes for several proteins that
are either proven (synaptojanin [10], intersectin [11,12], Dyrk1A [13,14]) or predicted (APP
[15], RCAN1 [16]) to influence SV recycling in central nerve terminals. SVs are retrieved by
three discrete endocytosis modes that are differentially recruited by neuronal activity. These
are ultrafast endocytosis [17], clathrin-mediated endocytosis (CME, [18]) and activity-depen-
dent bulk endocytosis (ADBE, [19]). CME forms single SVs directly from the plasma mem-
brane and is the dominant SV endocytosis mode during mild activity [20]. During elevated
neuronal activity ADBE is recruited to provide additional endocytic capacity. ADBE rapidly
forms large bulk endosome structures directly from the plasma membrane, which generate SVs
over time to replenish depleted pools [21]. The calcium-dependent protein phosphatase calci-
neurin (CaN) controls a number of events in the SV life cycle, including the number of avail-
able SVs [22], the speed of CME [23], triggering of ADBE [24,25] and SV generation from bulk
endosomes [26]. In DS brains, increased expression of the endogenous CaN inhibitor RCAN1
[27,28] suggests these events could be specifically perturbed.
The Ts65Dn mouse model of DS [29] carries a segmental trisomy of mouse chromosome 16
(Mmu16), containing orthologues of approximately half the protein encoding genes on Hsa21
[30]. Comparative studies in trisomic neurons have highlighted increases in presynaptic and
postsynaptic size [31], presence of enlarged endosomal structures [32], and alterations in neu-
ronal intracellular trafficking [33]. The Ts65Dn mouse also shows disrupted synaptic plasticity,
with decreased long-term potentiation (LTP) and increased long-term depression detectable in
the hippocampus [34–37]. Importantly, behavioural assays show learning and memory are
affected in these mice [38], strongly suggesting that the identified cellular defects are relevant
to neurological problems in DS.
Considering the genetic and endosomal trafficking links to SV endocytosis, we investigated
whether SV recycling was altered in the Ts65Dn mouse model. Using a combination of live
imaging assays and ultrastructural analysis, we found that both CME and ADBE were unaf-
fected in trisomic neurons. Thus, dysfunctional SV recycling is unlikely to precipitate the learn-
ing and memory defects in the Ts65Dn mouse, or by extension the neurological deficits that
occur in DS.
Methods
Reagents & antibodies
All general reagents were from Sigma-Aldrich (Gillingham, UK), and all tissue culture reagents
were from Life Technologies (Paisley, UK) unless otherwise stated. 6-Cyano-7-nitroquinoxa-
line-2,3-dione disodium salt (CNQX) and DL-2-amino-5-phosphonopentanoic acid sodium
salt (AP5) were from Abcam (Cambridge, UK), and bafilomycin A1 was from Cayman Chemi-
cal (Ann Arbor MI, USA). Sheep anti-dynamin PSer774 and sheep anti-dynamin PSer778
were from AbD Serotec (Kidlington, UK), goat anti-dynamin I was from Santa Cruz (Dallas,
USA), HRP-conjugated monoclonal mouse anti-β-actin (clone AC-15) and HRP-conjugated
rabbit anti-sheep/goat were from Sigma-Aldrich. Donkey anti-goat IRDye 680RD and donkey
anti-mouse IRDye 800CW were from LI-COR Biosciences (Cambridge, UK). The plasmid
encoding synaptophysin-pHluorin (syp-pHluorin) was a gift from Prof. L. Lagnado (University
of Sussex, UK).
Mouse maintenance, breeding and genotyping
All founder mouse stocks were obtained from the Jackson Laboratory. C57BL/6JEiJ (Jax stock
#000924) females were crossed with C3H/HeSnJ (Jax stock #000661) males to produce
B6EiC3SnF1/J litters. Male offspring from these crosses were set up in breeding pairs with
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B6EiC3Sn a/A-Ts(1716)65Dn/J (Ts65Dn) females (Jax stock #001924) to give litters containing
wildtype (2N) and trisomic pups. Genomic DNA was extracted from ear notch or tail biopsy
tissue using the HotSHOT technique [39] for genotyping, and trisomy carriers were detected
by chromosome breakpoint polymerase chain reaction [40]. In all cases, animals were culled by
UK Animal (Scientific Procedures) Act 1986 Schedule 1 procedures, in accordance with UK
Home Office Guidelines. All procedures were approved by the UK Home Office under Project
Licence 60/4290.
Cell culture and transfection
Neuronal cultures were generated in parallel from up to four pups from Ts65Dn litters, and
biopsy tissue from each individual animal was retained for genotyping. Cultures of hippocam-
pal neurons were made from pups on the day of birth (P0) as previously described [41], then
transfected using Lipofectamine 2000 at 7 days in vitro (DIV), and used in experiments from
13–16 DIV. Cultures of cerebellar granule neurons (CGN) were made from pups of either sex
aged between P5 –P7. Pups were culled, and the cerebellum dissected and digested with 0.025%
trypsin in Ca2+/Mg2+ free Hanks Balanced Salt Solution supplemented with 10 mMHEPES pH
7.3 for 20 min at 37°C. Digested tissue was washed in Dulbecco's Modified Eagle Medium sup-
plemented with 10% foetal bovine serum, 60 U/ml DNase and 1% penicillin/streptomycin, and
triturated in the same medium to obtain a single cell suspension. Cells were diluted to the
required density in Dulbecco's Modified Eagle Medium supplemented with 10% foetal bovine
serum and 1% penicillin/streptomycin, and plated in 75 μl spots on 25 mm glass coverslips
coated with 50 μg/ml poly-D-lysine. After 1 hour coverslips were flooded with Neurobasal
medium supplemented with 2% B27, 0.5 mM L-glutamine, an additional 20 mM KCl (total
concentration 25mM) and 1% penicillin/streptomycin. The following day the medium was fur-
ther supplemented with 2 μM cytosine β-D-arabinofuranoside. Cultures were used for experi-
ments after 8–10 DIV.
Dynamin I phosphorylation assays
Cultures of CGNs were repolarised for 10 min at room temperature in incubation buffer con-
taining (in mM): 170 NaCl, 3.5 KCl, 0.4 KH2PO4, 20 TES (N-[tris(hydroxymethyl)methyl]-
2-aminoethanesulfonic acid), 5 NaHCO3, 5 glucose, 1.2 Na2SO4, 1.2 MgCl2, 1.3 CaCl2, pH 7.4,
then rapidly lysed by boiling in sample buffer (67 mM SDS, 2 mM EDTA, 9.3% glycerol, 12%
β-mercaptoethanol, 0.02% bromophenol blue, 67 mM Tris, pH 6.8) for analysis of basal phos-
phorylation. In some experiments cells were depolarised in high KCl buffer (incubation buffer
with 50 mM KCl exchanged for 50 mMNaCl), or depolarised then left to repolarise for 10 min
in incubation buffer, before lysis.
Preparation of synaptosomes
Synaptosomes were prepared from adult female wildtype and trisomic Ts65Dn mice (11 weeks
old). Mice were culled by cervical dislocation and the forebrain was rapidly dissected out and
homogenised with a Dounce homogeniser in ice-cold homogenisation buffer containing (in
mM): 320 sucrose, 1 EDTA, 5 Tris, pH 7.4. The homogenate was initially centrifuged at
900 × g for 10 min at 4°C, and the supernatant (S1) was further centrifuged at 20200 × g for 10
min at 4°C to give a pellet (P2) enriched in synaptosomes. The synaptosomes were resuspended
in ice cold HEPES buffered Krebs containing (in mM): 118.5 NaCl, 4.7 KCl, 1.18 MgSO4, 10
glucose, 1 Na2HPO4, 20 HEPES, pH 7.4, then recentrifuged at 20200 × g for 10 min at 4°C, and
resuspended in HEPES buffered Krebs supplemented with 1.3 mM CaCl2. The synaptosomes
were incubated at 37°C for 10 min and then pelleted at 15900 × g for 2 min and rapidly lysed
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by boiling in sample buffer. Protein concentration from each synaptosome preparation was
estimated by Bradford Assay.
Western blotting
Samples in lysis buffer were separated by SDS-PAGE and transferred to a nitrocellulose mem-
brane. Blots from CGN lysates were blocked and probed with primary antibodies, washed
extensively, probed with HRP conjugated secondary antibodies, then washed again. Antibody
binding was detected by enhanced chemiluminescence and visualised with film. Blots from
synaptosome samples were prepared in the same way, but probed with IRDye conjugated sec-
ondary antibodies and scanned using an LI-COR Odyssey 9120 scanner (LI-COR Biosciences).
For all experiments, signals were quantified by densitometry using FIJI and normalised to a β-
actin loading control on the same blot prior to further analysis.
Fluorescence imaging of syp-pHluorin and dextran uptake
All fluorescence imaging was performed on a Zeiss Axio Observer D1 epifluorescence micro-
scope, equipped with a 40× 1.3NA EC Plan Neofluar oil immersion objective and Hamamatsu
Orca-ER camera. For pHluorin imaging, coverslips of cultured hippocampal neurons trans-
fected with syp-pHluorin were mounted in an imaging chamber with embedded parallel plati-
num electrodes (Warner RC-21BRFS), perfused at room temperature with imaging buffer
containing (in mM): 119 NaCl, 2.5 KCl, 2 CaCl2, 2 MgCl2, 25 HEPES, 30 glucose, 10 μM
CNQX and 50 μMAP5, adjusted to pH 7.4. In experiments to measure SV pool size, the imag-
ing buffer also contained 1 μM Bafilomycin A1 to inhibit SV acidification. Syp-pHluorin fluo-
rescence was imaged using 480 nm excitation and 510 nm long pass emission filters. Neurons
were electrically stimulated at 10 Hz with 1 ms pulses of 100 mA using a Digitimer D330 Multi-
Stim stimulator. At the end of each experiment, cultures were perfused with NH4Cl buffer
(imaging buffer with 50 mMNH4Cl exchanged for 50 mMNaCl) to deacidify all SVs and
reveal maximal syp-pHluorin fluorescence. Images were acquired at 4 s intervals and processed
using FIJI [42]. Regions of interest were placed over presynaptic terminals that responded to
action potential stimulation, and the fluorescence was measured using the Time Series Analy-
ser plugin. Fluorescence data were normalised to the maximal fluorescence obtained in NH4Cl
buffer to allow comparison between experiments.
Uptake of fluorescent dextran was measured and analysed as described previously [43]. In
brief, CGN cultures were repolarised for 10 min in incubation buffer, then electrically stimu-
lated as indicated in the presence of 50 μM tetramethylrhodamine-dextran (TMR-dextran, 40
kDa, Life Technologies). Cells were washed to remove uninternalised TMR-dextran, and 10
fields of view were captured from each coverslip using 550 nm excitation and 630/60 nm band
pass emission filters. Images were processed in FIJI using the Max Entropy thresholding algo-
rithm, and the number of fluorescent TMR-dextran puncta between 0.25–0.88 μm2 counted
using the Analyse Particles tool. Counts were corrected for non-specific background binding
by subtracting the number of puncta measured in unstimulated control coverslips from each
genotype.
Transmission electron microscopy of HRP uptake and endosome
budding
Cultures of CGNs were repolarised for 10 min in incubation buffer, then stimulated with 400
action potentials at 40 Hz in the presence of 10 mg/ml horse-radish peroxidase (HRP, Sigma-
Aldrich). Immediately following the end of stimulation, cultures were washed to remove unin-
ternalised HRP and then fixed with 2% glutaraldehyde in phosphate buffered salt solution.
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After washing in 100 mM Tris (pH 7.4), HRP was developed with 0.1% w/v 3,3'-diaminobenzi-
dine and 0.2% v/v hydrogen peroxide. After further washes in 100 mM Tris, cultures were
stained with 1% v/v osmium tetroxide for 30 min and processed for transmission electron
microscopy (TEM) as described previously [44].
SV budding from bulk endosomes labelled with HRP was measured and analysed as
described previously [45]. Briefly, cultures of CGNs were repolarised for 10 min in incubation
buffer, then depolarised in high KCl buffer containing 10 mg/ml HRP for 2 min. Cultures were
then washed to remove uninternalised HRP, allowed to recover in incubation buffer for 2 min,
and then immediately depolarised again twice for 30 sec in high KCl buffer with a 30 sec inter-
val to unload HRP labelled SVs. Finally, cultures were left to rest for 30 min in incubation
buffer to allow endosome budding to proceed. Samples were fixed at each of the load, unload
and rest steps, then developed and processed for transmission electron microscopy as above.
Images were acquired on an FEI Tecnai 12 transmission electron microscope, and analysed in
FIJI. HRP labelled structures with a diameter100 nm were arbitrarily classified as endo-
somes. Results are presented as HRP-labelled structures per nerve terminal cross section for
both SVs and bulk endosomes.
Statistical analysis
All data analysis was performed in Microsoft Excel and GraphPad Prism 6. Two-tailed
unpaired t-tests were used to compare two groups, one-way ANOVA with Holm-Šídák post-
hoc tests were used to compare more than two groups, and two-way ANOVA with Holm-
Šídák post-hoc tests were used to compare binned frequency distributions between groups. In
all analyses, the sample size (n) was taken to be the number of independent experiments. All
data are presented as mean values ± standard error of the mean (SEM).
Results
Enlarged endosomes are present in the neurons of DS patients and Ts65Dn mice [7,32] and a
number of endocytosis genes are part of the DS trisomy. We therefore investigated whether
altered SV recycling may underlie the synaptic defects observed in the Ts65Dn mouse. We first
determined whether activity-dependent SV exocytosis or endocytosis was perturbed in primary
hippocampal cultures derived from either trisomic mice or wild-type littermate controls. SV
turnover was monitored using the genetically-encoded fluorescent reporter synaptophysin-
pHluorin (syp-pHluorin) [20]. The fluorescent pHluorin moiety is exquisitely pH-sensitive,
and when fused within an intraluminal loop of the SV protein synaptophysin is quenched by
the acidic SV environment. During SV exocytosis syp-pHluorin is exposed to the neutral extra-
cellular environment and its fluorescence is unquenched. It is then retrieved via SV endocytosis
and the reformed SVs are rapidly acidified, quenching the reporter. SV acidification occurs
with faster kinetics than endocytosis [46], and therefore the recovery kinetics of the syp-
pHluorin response after stimulation provides a readout of SV endocytosis rate. Cultures were
stimulated with a train of 300 action potentials (10 Hz), which evoked a characteristic increase
in syp-pHluorin fluorescence, followed by a recovery to baseline on termination of stimulation
(Fig 1A and 1B). The peak syp-pHluorin response in trisomic neurons was not significantly
different to wild-type (Fig 1C), suggesting that there was no obvious difference in the extent of
SV exocytosis. Furthermore the time constant for syp-pHluorin fluorescence recovery after
stimulation was also not significantly different between genotypes (Fig 1D). This suggests CME
is unaffected in trisomic neurons, since it is the dominant SV endocytosis mode under these
stimulation conditions [47].
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CaN activity positively regulates the size of the SV recycling pool, defined as SVs that are
mobilised during action potential stimulation [22]. Since increased expression of RCAN1 in
Ts65Dn neurons [48] may alter CaN activity, we determined the size of the recycling pool. To
determine the recycling pool size, SV acidification in syp-pHluorin expressing neurons was
acutely blocked with Bafilomycin A1. This reveals the cumulative number of SVs that visit the
plasma membrane during a prolonged train of 1200 action potentials (10 Hz). In wild-type
neurons, action potential stimulation evoked a fluorescence increase that saturated over time,
indicating that the full SV recycling pool was mobilised (Fig 2A). Trisomic neurons displayed
an almost identical response (Fig 2A and 2B), indicating that either the size of the total SV
recycling pool (Fig 2C) or the rate at which it is mobilised (Fig 2D) is unaffected by the pres-
ence of the DS trisomy.
The presence of enlarged endosomes in both DS patients and Ts65Dn mice suggested a
potential defect in ADBE, since this endocytosis mode traffics SV cargo and membrane via
endosomal intermediates [21]. In support, CaN activity is required for triggering of ADBE
[24,25]. We first determined the effect of DS trisomy on the phosphorylation status of Ser774
and Ser778 on dynamin I, since CaN-dependent dephosphorylation of these residues is essential
for ADBE triggering [24]. We performed these experiments in primary cultures of CGNs, since
ADBE is best characterised in this system. The phosphorylation levels of either Ser774 or Ser778
were not significantly different between resting wild-type and trisomic neurons when assessed
by western blotting with phospho-specific antibodies (Fig 3). Similar results were also obtained
from isolated nerve terminals (synaptosomes) prepared from adult mice (Fig A in S1 File). We
next tested whether activity-dependent changes in dynamin I phosphorylation status were
affected by the presence of the Ts65Dn trisomy. Dynamin I was significantly dephosphorylated
Fig 1. Ts65Dn trisomy does not affect SV exocytosis or CME. A) Primary cultures of hippocampal
neurons expressing syp-pHluorin (syp-pH) from either trisomic (Ts) or wild-type (Wt) littermates were
stimulated with a train of 300 action potentials (10 Hz). Cultures were when left to recover before a pulse of
NH4Cl buffer was applied. Representative false colour images display a transfected neuron (Wt or Ts) either
at rest (Basal), during stimulation (10 Hz), 2 min after stimulation (Recovery) and during challenge with NH4Cl
buffer. Scale bar represents 3 μm. B) Mean fluorescence traces ± SEM (ΔF/F0) normalised to peak
fluorescence obtained in NH4Cl buffer (black circles, Wt; red circles Ts). Stimulation is indicated by bar. C)
Mean peak normalised syp-pH fluorescence during stimulation ± SEM. D) Mean time constant (τ) for post-
stimulation fluorescence recovery ± SEM (n = 5Wt, n = 9 Ts, two-tailed unpaired t-test, ns = p > 0.05).
doi:10.1371/journal.pone.0147974.g001
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on both Ser774 and Ser778 during a hyperkalaemic depolarising stimulus in wild-type CGNs,
and was fully rephosphorylated during a 10 minute rest period (Fig 4). Dynamin I displayed a
very similar phosphorylation profile in trisomic CGNs (Fig 4). This absence of effect on dyna-
min I phosphorylation was not due to alterations in total dynamin I, since this was unaffected
by both stimulation and genotype (Fig B in S1 File). Therefore activity-dependent dephosphory-
lation of dynamin I by CaN and its rephosphorylation after stimulation was unaffected by the
Ts65Dn trisomy.
The lack of effect on CaN-mediated dynamin I dephosphorylation suggested that ADBE
may be unaltered in trisomic neurons. We determined this directly by monitoring uptake of
the large (40 kDa) fluid phase marker TMR-dextran. TMR-dextran selectively reports ADBE
since its size prevents its accumulation into SVs retrieved via CME [47]. Delivery of a high fre-
quency train of 400 action potentials (40 Hz) evoked a robust increase in TMR-dextran uptake
in wild-type CGNs (Fig 5A and 5B). A train of lower frequency action potentials (10 Hz for 20
sec) failed to evoke any TMR-dextran uptake, confirming activity-dependent triggering of
ADBE [47]. When these experiments were repeated in trisomic CGNs, no differences in TMR-
dextran uptake were observed when compared to wild-type (Fig 5A and 5B), suggesting that
the Ts65Dn trisomy has no effect on either the triggering threshold or overall extent of ADBE.
To confirm that both CME and ADBE were unaffected in trisomic neurons, we also exam-
ined uptake of the fluid phase marker HRP at the ultrastructural level. This assay provides
straightforward discrimination of CME and ADBE via the generation of HRP-labelled SVs and
endosomes respectively [47]. CGNs were challenged with a train of intense neuronal activity
Fig 2. Ts65Dn trisomy does not affect the SV recycling pool. A) Primary cultures of hippocampal neurons
expressing syp-pHluorin (syp-pH) from either trisomic (Ts) or wild-type (Wt) littermates were stimulated with a
train of 1200 action potentials (10 Hz) in the presence of Bafilomycin A1 (Baf) before a pulse of NH4Cl buffer
was applied. Representative false colour images display a transfected neuron (Wt or Ts) either at rest
(Basal), during stimulation (10 Hz + Baf) or during challenge with NH4Cl buffer. Scale bar represents 2 μm. B)
Mean fluorescence traces ± SEM (ΔF/F0) were normalised to peak fluorescence obtained in NH4Cl buffer
(black circles, Wt; red circles Ts). C) Mean peak normalised syp-pH fluorescence during stimulation ± SEM.
D) Mean initial rate of syp-pHluorin increase on stimulation ± SEM (n = 5 for both genotypes, two-tailed
unpaired t-test, ns = p > 0.05).
doi:10.1371/journal.pone.0147974.g002
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(40 Hz 10 s) in the presence of HRP and then immediately fixed. The number of HRP-labelled
SVs or endosomes per nerve terminal were not significantly different between genotypes (Fig
5C and 5D). The lack of phenotype was not due to changes in nerve terminal area, since this
parameter was also unchanged (Fig C in S1 File). This confirms that both CME and ADBE
were unaffected by the Ts65Dn trisomy.
Finally, we tested whether SV generation from bulk endosomes was affected by the DS tri-
somy, since this process also requires CaN activity [26]. We used a characterised morphological
assay [49] that tracks the fate of SVs generated from bulk endosomes. In this assay CGNs are
challenged with intense stimulation in the presence of HRP, generating HRP-labelled SVs and
endosomes. CGNs are then immediately challenged with an identical stimulus to selectively
deplete HRP-labelled SVs formed by CME. CGNs are left to recover, following which the
Fig 3. Ts65Dn trisomy has no effect on basal phosphorylation of dynamin I.Wild-type (Wt) and trisomic
(Ts) CGNs were lysed and the phosphorylation status of either Ser774 (PSer774) or Ser778 (PSer778) on
dynamin I (DynI) was monitored by western blotting with phospho-specific antibodies. A) Representative
blots are displayed fromWt and Ts CGN lysates probed with either PSer774 or PSer778 antibodies and actin
loading controls. B) Mean phosphorylation levels of either PSer774 or PSer778 normalised to actin are
displayed in either Wt (black bars) or Ts (red bars) CGNs ± SEM. Data are presented normalised to Wt
(n = 10 PSer774; n = 11 PSer778, two-tailed unpaired t-test, ns = p > 0.05.
doi:10.1371/journal.pone.0147974.g003
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Fig 4. Ts65Dn trisomy has no effect on activity-dependent phosphorylation of dynamin I.Wild-type
(Wt) and trisomic (Ts) CGNs were lysed either in basal conditions (B), after 30 s depolarisation with 50 mM
KCl (K) or after 10 min of repolarisation (R). The phosphorylation status of either Ser774 (PSer774, A) or
Ser778 (PSer778, B) on dynamin I (DynI) was monitored by western blotting with phospho-specific
antibodies. Representative blots are displayed fromWt and Ts CGN lysates probed with either PSer774 or
Synaptic Vesicle Recycling in Down Syndrome
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number of new HRP-labelled SVs that are generated from bulk endosomes can be quantified
(Fig 6A and 6B). We observed no difference in either the generation, depletion or reformation
of HRP-labelled SVs when wild-type and trisomic CGNs were compared (Fig 6C), suggesting
that the Ts65Dn trisomy does not affect SV generation from bulk endosomes. This was con-
firmed by monitoring the size of HRP-labelled bulk endosomes, since their diameter decreases
as they donate membrane to generate new SVs [49]. No genotype-dependent difference in the
diameter of HRP-labelled endosomes was observed immediately after HRP loading (Fig 6D).
The diameter of HRP-labelled endosomes then decreased to the same extent after the 30 min-
ute rest period in both wild-type and trisomic CGNs, indicating that they had generated a simi-
lar number of SVs (Fig 6D). Together these results indicate that SV budding from bulk
endosomes formed by ADBE is unaffected by the Ts65Dn trisomy.
Discussion
A number of genes within the DS trisomy encode proteins that are either implicated or directly
involved in the control of SV recycling, suggesting SV recycling could be altered in this condi-
tion. In support, neurons derived from mouse models of DS display altered plasticity and
PSer778 antibodies and actin loading controls. Mean phosphorylation levels of either PSer774 (A) or
PSer778 (B) normalised to actin and basal phosphorylation are displayed in either Wt (black bars) or Ts (red
bars) CGNs ± SEM (n = 4 PSer774; n = 3 PSer778, one-way ANOVA with Holm-Šídák, ns = p > 0.05.
doi:10.1371/journal.pone.0147974.g004
Fig 5. Ts65Dn trisomy has no effect on ADBE. A,B) Wild-type (Wt) and trisomic (Ts) CGNs were
challenged with trains of action potentials (either 10 Hz 20 s or 40 Hz 10 s) in the presence of 50 μM TMR-
dextran. TMR-dextran was immediately washed away on termination of stimulation. A) Representative
images of TMR-dextran uptake are displayed, scale bar indicates 20 μm. B) Mean number of TMR-dextran
puncta detected per field of view in each condition for either Wt (black bars) or Ts (red bars) neurons ± SEM
(n = 6, Wt 10 Hz; n = 10, Wt 40 Hz; n = 5, Ts 10 Hz; and n = 10, Ts 40 Hz) independent experiments for each
condition, one-way ANOVA with Holm-Šídák, ns = p > 0.05. C, D) CGNs were challenged with a train of 400
action potentials (40 Hz) in the presence of 10 mg/ml HRP. C) Representative images show a typical HRP-
labelled endosome (Endo) and synaptic vesicle (SV) in either Wt or Ts nerve terminals. Scale bar represents
500 nm. D) Mean number of HRP-labelled endosomes and SVs per nerve terminal for either Wt (black bars)
or Ts (red bars) neurons is displayed ± SEM (n = 3 independent experiments for each genotype, two-tailed
unpaired t-tests, ns = p > 0.05).
doi:10.1371/journal.pone.0147974.g005
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Fig 6. Ts65Dn trisomy has no effect on SV generation from bulk endosomes. A)Wild-type (Wt) and
trisomic (Ts) CGNs were stimulation with 50 mM KCl for 2 min in the presence of 10 mg/ml HRP. After 2 min
CGNs were challenged with 2 consecutive 30 s KCl stimuli (50 mM) and then left to rest for 30 min. CGNs
were fixed either immediately after loading (Load), after the two consecutive KCl stimuli (Unload) or after the
30 min rest period (Rest). B) Representative images show a typical HRP-labelled endosome (Endo) and
synaptic vesicle (SV) in either Wt or Ts nerve terminals in either Load, Unload or Rest conditions. Scale bar
represents 500 nm. C) Mean number of HRP-labelled SVs per nerve terminal for either Wt (black bars) or Ts
(red bars) neurons is displayed for either the Load, Unload or Rest conditions ± SEM (n = 3 coverslips for
each genotype, one-way ANOVA with Holm-Šídák, ns = p > 0.05). D) Frequency histogram displaying the
diameter of HRP-labelled endosomes in either Wt or Ts nerve terminals at either the Load or Rest conditions
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ultrastructural changes consistent with altered endocytic or trafficking processes. However, we
found that in Ts65Dn mice, key parameters of neuronal SV recycling were indistinguishable
from wild-type controls. This suggests that SV recycling may be unaffected in DS and does not
contribute to the neurological problems displayed in the condition.
The Ts65Dn mouse is currently the best characterised model of DS, and has been widely
used for preclinical testing of drugs to treat learning and memory impairments in DS [50]. It is
an imperfect model however, carrying a segmental trisomy of Mmu16 containing orthologues
of only 88 of the 157 conserved protein encoding genes found on Hsa21 [30]. Furthermore it
carries an additional 60 annotated genes from Mmu17 within its trisomy that do not have
orthologues on Hsa21 [51]. Nonetheless, the Ts65Dn mouse displays several important hall-
marks of DS, including deficits in learning and memory [38], selective neurodegeneration of
cholinergic neurons [52] and the presence enlarged Rab5-positive endosomes within the brain
[32,33]. Thus while the Ts65Dn mouse is a reasonable model of DS, we cannot rule out that dif-
ferences in SV recycling may be present in other mouse models containing trisomies more
closely resembling Hsa21 [38].
As stated above the Ts65Dn mouse displays neurodegeneration, in agreement with the
increased incidence of Alzheimer’s Disease in DS patients [53]. Presynaptic dysfunction pre-
cedes neurodegeneration in a number of preclinical models [54,55] suggesting this may in part
precipitate this event. We were unable to determine whether presynaptic dysfunction occurs in
aged Ts65Dn mice, since primary neuronal cultures can only be currently prepared from
embryonic or neonatal tissue. It is therefore possible that the enlarged Rab5-positive endo-
somes observed in Ts65Dn neurons may cause presynaptic dysfunction later in life. However it
should be considered that DS is primarily a neurodevelopmental disorder, with neurological
deficits present from birth.
Among the trisomic Hsa21 gene orthologues the Ts65Dn mouse carries, there are several
with potential relevance to SV recycling including Synj1, Itsn1, Rcan1, App and Dyrk1a. The
CaN inhibitor RCAN1 was of particular interest, since RCAN1 is thought to inhibit CaN activ-
ity [28,56,57] and CaN activity is required for multiple aspects of the SV life cycle [22–26].
Indeed CaN knockout mice display impaired neurotransmission during intense stimulation
and prominent hyperphosphorylation of proteins involved in the SV cycle including dynamin
I [58]. CaN knockout mice also show deficits in working memory [59,60], indicating that the
differences in neurotransmission in the absence of CaN activity have profound effects on nor-
mal cognition. In tissue from DS brains, RCAN1 protein expression is increased [27,28], and
over-expression of RCAN1 in secretory cells negatively regulates granule fusion [61] and endo-
cytosis [16]. Furthermore mice over-expressing RCAN1 also show reduced LTP maintenance,
accompanied by behavioural deficits in learning and memory [62]. A direct link between
RCAN1 expression and CaN activity has been made, with RCAN1 knockout mice displaying
increased CaN activity in hippocampal lysates [63]. However, transgenic mice overexpressing
RCAN1 display no alterations in hippocampal CaN activity [62]. This suggests that increased
Rcan1 gene dosage such as observed in DS trisomy may be insufficient to inhibit CaN activity,
in agreement with our results.
Both intersectin-1 and synaptojanin have established roles in CME at synapses [10,11,64].
Furthermore the protein kinase Dyrk1a phosphorylates both synaptojanin-1 [14,65] and
RCAN1 [66], suggesting possible synergistic effects of these trisomic genes [67]. Dyrk1a phos-
phorylates several other CME proteins including amphiphysin, dynamin, AP180 and α- and β-
(n = 3 independent experiments for each genotype, two-way ANOVA with Holm-Šídák, *** = p < 0.001, * =
p < 0.05, all other conditions ns = p > 0.05).
doi:10.1371/journal.pone.0147974.g006
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adaptins [68–70], suggesting it plays a potential regulatory role during CME. Our studies using
both the genetically-encoded SV cargo syp-pHluorin, and uptake of fluid phase HRP, have
shown that both the kinetics and extent of CME are unaffected in Ts65Dn neurons.
Enlarged Rab5-positive early endosomes are present in neurons from both pre-birth DS
patients [7], and Ts65Dn mice [32]. This defect is linked to cholinergic neuron degeneration
due to NGF transport failure [33] and altered synaptic neurotrophin signalling [71]. APP plays
a key role in the formation of these enlarged endosomes, since normalisation to two copies of
APP in trisomic mice stops their formation. However, APP over-expression alone is not suffi-
cient to induce endosomal pathology, showing that other trisomic genes must contribute to the
effect [32]. One candidate is synaptojanin-1, since it is essential for the formation of enlarged
early endosomes in lymphoblastoid cell lines derived from DS patients [72]. Since synaptojanin
also plays a key role in SV endocytosis, this presents a potential cross-over between DS endoso-
mal pathology and SV recycling pathways. In addition, accumulating evidence suggest that
classical endosomal trafficking pathways may intersect with multiple SV endocytosis modes
[8] suggesting the pathogenic processes that lead to enlarged early endosomes could either feed
through to, or originate at, the presynapse. However the fact that that CME, ADBE and SV
generation from bulk endosomes are unaffected by trisomy in Ts65Dn neurons, indicates that
the acquisition of endosomal pathology and SV recycling pathways are most likely uncon-
nected in DS.
In acute hippocampal slices from Ts65Dn mice, basal transmission appears normal [36], in
agreement with our finding that SV exocytosis and recycling pool size is unaffected by the tri-
somy. In contrast, hippocampal LTP induction is strongly reduced in Ts65Dn mice, which is
most likely caused by excessive GABAergic inhibition [35–37,73]. Encouragingly, recent stud-
ies have shown that pharmacological antagonism of post-synaptic GABAA receptors can rescue
behavioural deficits in learning and memory in Ts65Dn mice [74,75]. Our data reveals an
absence of presynaptic dysfunction in the central nerve terminals of Ts65Dn mice, suggesting
that future pharmacotherapy should continue to focus on the established alterations in excit-
atory / inhibitory balance at the circuit level.
Supporting Information
S1 File. Fig A) Forebrain synaptosomes from either wild-type (Wt) and trisomic (Ts) mice
were lysed and the phosphorylation status of either Ser774 (PSer774) or Ser778 (PSer778) on
dynamin I (DynI) was monitored by western blotting with phospho-specific antibodies. Repre-
sentative blots are displayed fromWt and Ts synaptosome lysates probed with either PSer774
or PSer778 antibodies and actin loading controls. Mean phosphorylation levels of either Ser774
or Ser778 normalised to actin are displayed in either Wt (black bars) or Ts (red bars) synapto-
some lysates ± SEM. Data are presented normalised to Wt (n = 3 animals for each genotype,
two-tailed unpaired t-test, ns = p> 0.05). Fig B)Wild-type (Wt) and trisomic (Ts) CGNs were
lysed either in basal conditions, after 30 s depolarisation with 50 mM KCl. The effect of geno-
type or stimulation on total dynamin I (DynI) was monitored by western blotting with dyna-
min antibodies. Representative blots are displayed fromWt and Ts CGN lysates probed with
DynI antibodies and actin loading controls. Mean DynI levels normalised to actin are displayed
in either Wt (black bars) or Ts (red bars) CGNs ± SEM (n = 3), one-way ANOVA with Holm-
Šídák, ns = p> 0.05. Fig C) CGNs were challenged with a train of 400 action potentials (40
Hz) in the presence of 10 mg/ml HRP. The mean nerve terminal area (μm2) is displayed in
either wild-type (Wt, black bars) or trisomic (Ts, red bars) neurons ± SEM (n = 3 coverslips for
each genotype with 50 nerve terminals examined per coverslip). Fig D) Uncropped original
Western blots from Fig 3. Fig E) Uncropped original Western blots from Fig 4. Fig F)
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Uncropped original Western blots from Fig A. Fig G) Uncropped original Western blots from
Fig B.
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